226
|
Epstein N, Epstein M, Boulet A, Fibach E, Rodgers GP. Monoclonal antibody-based methods for quantitation of hemoglobins: application to evaluating patients with sickle cell anemia treated with hydroxyurea. Eur J Haematol 1996; 57:17-24. [PMID: 8698126 DOI: 10.1111/j.1600-0609.1996.tb00484.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
High-titer monoclonal antibodies (mAb) were raised against chromatographically purified human hemoglobin (Hb) species. These mAb were specific for either Hb A, Hb F, Hb S or Hb C. Based on these antibodies, which were directly conjugated with either fluorochromes or an enzyme (horseradish peroxidase), we developed immunoassays for determining the Hb profile in the peripheral blood; an enzyme-linked immunosorbent assay (ELISA) for determining the absolute and relative quantities of various Hb species and one-step immunolabeling for fluorescence microscopic and flow cytometric analyses of the distribution of RBC with respect to their Hb types. We utilized these methods for monitoring the Hb F level and the percentage of Hb F-containing cells in patients with sickle cell anemia undergoing treatment with hydroxyurea.
Collapse
|
227
|
Arrington J, Anthony P, Arnold RG, Beise EJ, Belz JE, Bosted PE, Bulten H, Chapman MS, Coulter KP, Dietrich F, Ent R, Epstein M, Filippone BW, Gao H, Gearhart RA, Geesaman DF, Hansen J, Holt RJ, Jackson HE, Jones CE, Keppel CE, Kinney ER, Kuhn S, Lee K, Lorenzon W, Lung A, Makins NC, Margaziotis DJ, McKeown RD, Milner RG, Mueller B, Napolitano J, Nelson J, O'Neill TG, Papavassiliou V, Petratos GG, Potterveld DH, Rock SE, Spengos M, Szalata ZM, Tao LH, White JL, Winter D, Zeidman B. Inclusive electron scattering from nuclei at x~=1. PHYSICAL REVIEW. C, NUCLEAR PHYSICS 1996; 53:2248-2251. [PMID: 9971203 DOI: 10.1103/physrevc.53.2248] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
228
|
Allinger TL, Epstein M, Herzog W. Stability of muscle fibers on the descending limb of the force-length relation. A theoretical consideration. J Biomech 1996; 29:627-33. [PMID: 8707789 DOI: 10.1016/0021-9290(95)00087-9] [Citation(s) in RCA: 50] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
For the past 40 years it has generally been accepted that the descending limb of the force-length (F-L) relation of muscle fibers is unstable; strong sarcomeres are thought to shorten onto the ascending limb of the F-L relation at the expense of weak sarcomeres which are stretched beyond the thin-thick myofilament overlap. This unstable behavior has not been demonstrated by direct observation but has been inferred indirectly, based on the negative slope of the F-L relation. Intuitively, the idea that the sarcomere length within skeletal muscle is unstable at any length within the normal working range would not be advantageous. Therefore, the purpose of this study was to identify analytically the mechanical conditions for which sarcomeres in a muscle fiber are stable. It was found that the mechanical conditions required for sarcomere and fiber stability could be associated with known properties of skeletal muscle fibers. Furthermore, it could be demonstrated that a fiber composed of a large number of sarcomeres can be stable, and still exhibit an apparently unstable (negatively sloped) descending limb of the F-L curve.
Collapse
|
229
|
Friedman JH, Epstein M, Sanes JN, Lieberman P, Cullen K, Lindquist C, Daamen M. Gamma knife pallidotomy in advanced Parkinson's disease. Ann Neurol 1996; 39:535-8. [PMID: 8619532 DOI: 10.1002/ana.410390416] [Citation(s) in RCA: 44] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Posteroventral pallidotomy as a treatment for Parkinson's disease (PD) has been the subject of increasing interest. We treated 4 nondemented patients with advanced PD, 2 with severe bradykinesia and a declining response to medication, and 2 with marked clinical fluctuations. All patients received 180 Gy delivered in one sitting to the right posteroventral pallidum site, used by Laitinen and colleagues, adjusted as needed, to avoid the optic tract. Only 1 patient changed significantly. Dyskinesia completely resolved on the side contralateral to the lesion in this patient. This same patient also became transiently demented and psychotic. The other 3 patients suffered no clearly identifiable beneficial or harmful effects. Follow-up magnetic resonance imaging scans of the brain at 1 year revealed lesions exactly where targeted although of unequal sizes. Our negative experience forces us to conclude that either larger volumes of tissue must be ablated, that physiologic monitoring is required for placing a lesion, that our subjects were poor candidates for the procedure, or that surgical ablation and radiation cause tissue damage of different types with different results.
Collapse
|
230
|
Preston RA, Singer I, Epstein M. Renal Parenchymal Hypertension: current concepts of pathogenesis and management. ARCHIVES OF INTERNAL MEDICINE 1996; 156:602-11. [PMID: 8629871 DOI: 10.1001/archinte.156.6.602] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Renal parenchymal disease is a common but often unrecognized cause of hypertension. Chronic renal disease and systemic hypertension may coexist in two distinct settings. First, essential hypertension is an important cause of chronic renal disease. Second, renal parenchymal disease is a well-established cause of secondary hypertension. Renal parenchymal disease is the most common cause of secondary hypertension, accounting for 2.5% to 5.0% of all cases of systemic hypertension. Secondary hypertension may also accelerate the decline in renal function if inadequately controlled. Therefore, hypertension is both a cause and a consequence of renal disease, and it may be difficult to distinguish them clinically.
Collapse
|
231
|
Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 1996; 19:31-6. [PMID: 8829821 DOI: 10.1291/hypres.19.31] [Citation(s) in RCA: 85] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Although calcium antagonists reduce systemic blood pressure, the effects of calcium antagonists on renal preglomerular and postglomerular microcirculation have been suggested to differ. In the present study we examined the vasodilator action of dihydropyridine-type calcium antagonists, including nifedipine, nicardipine, amlodipine, and efonidipine, on afferent and efferent arterioles during angiotensin II (A-II)- and norepinephrine (NE)-induced renal vasoconstriction. Isolated perfused hydronephrotic kidneys were used to directly visualize renal microcirculatory response to calcium antagonists. Both A-II and NE caused marked vasoconstriction of afferent (A-II, 27 +/- 2% decrement; NE, 28 +/- 2% decrement) and efferent arterioles (A-II, 25 +/- 4% decrement; NE, 22 +/- 2% decrement). The subsequent addition of nifedipine, nicardipine, and amlodipine reversed the afferent arteriolar vasoconstriction in a dose-dependent manner, and elicited complete vasodilation at 10(-6) M. In contrast, efferent arteriolar vasoconstriction was relatively refractory to the dilator action of these calcium antagonists; maximal dilation observed at 10(-6) M was 21 +/- 1% (A-II) and 22 +/- 3% (NE) for nifedipine, 25 +/- 3% (A-II) and 20 +/- 6% (NE) for nicardipine, and 39 +/- 6% (A-II) and 37 +/- 3% (NE) for amlodipine. In striking contrast, efonidipine dilated not only afferent arterioles, but also efferent arterioles in a dose-dependent manner. At 10(-6) M, efonidipine completely inhibited the afferent (A-II, 89 +/- 7% reversal; NE, 99 +/- 8% reversal) and efferent arteriolar vasoconstriction (A-II, 93 +/- 4% reversal; NE, 87 +/- 9% reversal). These findings clearly demonstrate that calcium antagonists dilate the afferent arteriole. Unlike the effects on the afferent arteriole, efferent arteriolar responsiveness to calcium antagonists differ, depending on the type of calcium antagonist. The efonidipine-induced efferent arteriolar vasodilation is probably not related to voltageoperated calcium channels, and may act, in concert with blood pressure lowering effect, to ameliorate glomerular capillary hypertension.
Collapse
|
232
|
|
233
|
Grimmond SM, Teh BT, Hii SI, Cardinal J, Walters M, Epstein M, Edwards M, Hockey A, Pullan PT, Perry-Keene D, Boyages S, Cameron D, Hayward NK. Predictive diagnosis of multiple endocrine neoplasia (MEN 1) in four Australian kindreds. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE 1996; 26:27-32. [PMID: 8775525 DOI: 10.1111/j.1445-5994.1996.tb02903.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
BACKGROUND Multiple endocrine neoplasia type 1 (MEN 1) is a tumour predisposition syndrome that usually manifests in the first four decades of life. It has an autosomal dominant mode of inheritance which means that any new member of a MEN1 kindred has roughly a 50% chance of developing the disorder during their lifetime. The localisation of the MEN1 gene to a small region of chromosome band 11q13 has led to the development of DNA-based predictive diagnosis for this disease. AIMS To establish a polymerase chain reaction (PCR)-based system, using simple tandem repeat polymorphisms (STRPs), to predict gene carriers in four Australian MEN 1 kindreds. METHODS Six STRP markers flanking the MEN1 region of chromosome band 11q13 were used to screen individuals for a common haplotype in order to determine carrier status. RESULTS The accuracy of prediction was calculated to be > 95% in informative individuals. CONCLUSIONS DNA-based presymptomatic detection of affected members of MEN 1 kindreds could facilitate their care and reduce the inconvenience and expense of repeated testing of unaffected members. However, due to occasional recombination events or uninformativeness of markers in certain individuals, carrier status cannot always be predicted.
Collapse
|
234
|
Vesely DL, Preston R, Gower WR, Chiou S, Epstein M. Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans. Am J Nephrol 1996; 16:128-37. [PMID: 8919229 DOI: 10.1159/000168984] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Kaliuretic peptide is a recently discovered potent stimulator of potassium and water excretion. Its role in modulating renal water handling in cirrhotic patients has not been defined. The responses of circulating kaliuretic peptide and atrial natriuretic factor in 8 cirrhotic subjects to water immersion were significantly greater (p < 0.05) than those of 7 healthy volunteers. With cessation of immersion, atrial natriuretic factor decreased within 30 min to preimmersion values, whereas kaliuretic peptide remained significantly elevated > 1 h, suggesting a slower clearance for kaliuretic peptide. The peak diuretic response to immersion corresponded in a temporal fashion to the peak circulating concentration of kaliuretic peptide, suggesting a possible physiological role of kaliuretic peptide in modulating volume homeostasis in cirrhotic humans.
Collapse
|
235
|
Schattner A, Epstein M, Berrebi A, Caspi A. Case report: multiple myeloma presenting as a diastolic heart failure with no evidence of amyloidosis. Am J Med Sci 1995; 310:256-7. [PMID: 7503107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
The development of severe right sided congestive heart failure led to a diagnosis of immunoglobulin G (lambda) myeloma with a predominance of light chains. Cardiac catheterization and endomyocardial biopsy showed a severe diastolic dysfunction of both right and left ventricles and extensive myocardial infiltration by intercellular fibrillar tissue, which was not amyloid. This is a rare presentation of immunoglobulin deposition disease associated with immunocytic dyscrasias.
Collapse
|
236
|
Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995; 26:869-79. [PMID: 7490142 DOI: 10.1161/01.hyp.26.6.869] [Citation(s) in RCA: 297] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Because considerable important information has been published since our previous review, this update concentrates on new findings with regard to cardiovascular and renal risk factors contributing to the striking morbidity and mortality of these coexisting diseases. For example, a large body of investigative data has recently emerged suggesting or delineating a pathogenic role for hyperglycemic-related glycosylation and oxidation of lipoproteins and vascular and renal tissues. Great strides have recently been made in the understanding of platelet, coagulation, lipoprotein, and endothelial abnormalities in the pathogenesis of cardiovascular and renal disease associated with diabetes mellitus and hypertension. Major progress has been made in clarifying the pathophysiology of glomerulosclerosis and other processes involved in the progression of diabetic nephropathy. Furthermore, accumulating data surveyed in this review address new and promising pharmacological interventions that specifically address these pathophysiological mechanisms.
Collapse
MESH Headings
- Adrenergic alpha-Antagonists/therapeutic use
- Adrenergic beta-Antagonists/therapeutic use
- Adult
- Aged
- Angiotensin-Converting Enzyme Inhibitors/therapeutic use
- Arteriosclerosis/etiology
- Arteriosclerosis/metabolism
- Benzothiadiazines
- Calcium Channel Blockers/therapeutic use
- Cardiovascular Diseases/etiology
- Cells, Cultured
- Diabetes Complications
- Diabetes Mellitus/physiopathology
- Diabetes Mellitus/therapy
- Diabetes Mellitus, Type 1/complications
- Diabetes Mellitus, Type 1/therapy
- Diabetes Mellitus, Type 2/complications
- Diabetes Mellitus, Type 2/therapy
- Diabetic Nephropathies/metabolism
- Diabetic Nephropathies/physiopathology
- Diuretics
- Endothelium, Vascular/physiology
- Female
- Humans
- Hyperglycemia/complications
- Hypertension/complications
- Hypertension/physiopathology
- Hypertension/therapy
- Insulin/physiology
- Insulin-Like Growth Factor I/physiology
- Lipoproteins/blood
- Male
- Muscle, Smooth, Vascular/cytology
- Muscle, Smooth, Vascular/metabolism
- Platelet Adhesiveness
- Platelet Aggregation
- Sexual Dysfunction, Physiological/etiology
- Sodium Chloride Symporter Inhibitors/therapeutic use
Collapse
|
237
|
|
238
|
Epstein M. Calcium antagonists should continue to be used for first-line treatment of hypertension. ARCHIVES OF INTERNAL MEDICINE 1995; 155:2150-6. [PMID: 7487236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
|
239
|
Epstein M. Calcium antagonists should continue to be used for first-line treatment of hypertension. ACTA ACUST UNITED AC 1995. [DOI: 10.1001/archinte.155.20.2150] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
240
|
Ent R, Anthony PL, Arnold RG, Arrington J, Beise EJ, Belz JE, Bosted PE, Bulten H, Chapman MS, Coulter KP, Dietrich FS, Epstein M, Filippone BW, Gao H, Gearhart RA, Geesaman DF, Hansen J, Holt RJ, Jackson HE, Jones CE, Keppel CE, Kinney ER, Kuhn S, Lee K, Lorenzon W, Lung A, Makins NC, Margaziotis DJ, McKeown RD, Milner RG, Mueller B, Napolitano J, Nelson J, O'Neill TG, Papavassiliou V, Petratos GG, Potterveld DH, Rock SE, Spengos M, Szalata ZM, Tao LH, Wasson DA, White JL, Zeidman B. Evidence for virtual Compton scattering from the proton. PHYSICAL REVIEW. D, PARTICLES AND FIELDS 1995; 52:4868-4871. [PMID: 10019711 DOI: 10.1103/physrevd.52.4868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
241
|
Inoue CN, Forster HG, Epstein M. Effects of lysophosphatidic acid, a novel lipid mediator, on cytosolic Ca2+ and contractility in cultured rat mesangial cells. Circ Res 1995; 77:888-96. [PMID: 7554142 DOI: 10.1161/01.res.77.5.888] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Lysophosphatidic acid (LPA), the smallest and structurally simplest phospholipid, has the potential to modulate cellular signaling in diverse tissues and cell types, including fibroblasts. In the present study, we assessed the effects of LPA on cultured rat glomerular mesangial cells. Quantitative changes of [Ca2+]i in response to LPA were measured in monolayers of mesangial cells loaded with the fluorescent Ca2+ indicator fura 2. LPA (10 nmol/L to 100 mumol/L) increased [Ca2+]i in a dose-dependent manner and evoked inositol trisphosphate formation. LPA (1 mumol/L to 30 mumol/L) also elicited a marked, albeit transient, contractile response in mesangial cells cultured on collagen gel, as assessed by a decrease in cell surface area (CSA). The contraction persisted for 5 minutes (CSA decreased by 31%), whereupon the mesangial cells gradually relaxed with a consequent increase in CSA. Pretreatment of mesangial cells with isradipine (1 mumol/L), a dihydropyridine-sensitive Ca2+ channel blocker, completely blocked LPA-induced contraction. Isradipine also decreased resting [Ca2+]i levels as well as the peak and the subsequently sustained [Ca2+]i levels induced by LPA, suggesting that the contractile effects of LPA are dependent on Ca2+ entry through voltage-gated Ca2+ channels. Finally, LPA stimulated an increase in both prostaglandin E2 synthesis and cAMP accumulation, indicating that these mediators may modulate the contractile effects of LPA. Our study is the first demonstration that exogenous LPA induces mesangial cell contraction and suggests that the contraction is mediated by mobilization of intracellular Ca2+ by activation of the phosphoinositide cascade as well as by promotion of Ca2+ entry across the plasma membrane.
Collapse
|
242
|
Feld S, Epstein M, Ayzenberg O, Caspi A. Non-visualized left anterior descending artery revealed on selective conus artery catheterization. Clin Cardiol 1995; 18:597-8. [PMID: 8785908 DOI: 10.1002/clc.4960181014] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Cardiac catheterization of a man with severe angina and anterior ischemia on exercise testing with perfusion imaging demonstrated normal anterior wall motion resting left ventriculography, but failed to visualize the left anterior descending (LAD) or conus artery on left and right coronary angiography. Selective contrast injection of a large conus artery originating from a separate ostium in the right aortic sinus demonstrated extensive collateral circulation to an LAD occluded at its origin from the left main coronary artery, thus providing essential information for subsequent patient management.
Collapse
|
243
|
Epstein M. Renal sodium retention in liver disease. Hosp Pract (1995) 1995; 30:33-7, 41-2. [PMID: 7559835 DOI: 10.1080/21548331.1995.11443256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In many patients with cirrhosis, salt retention eventually culminates in ascites and edema. The pathogenesis probably involves several hormonal and neural effectors acting in concert. When conservative therapy with diet and diuretics fails to mobilize fluid, options for more intensive treatment include large-volume paracentesis and the transjugular intrahepatic portosystemic shunt.
Collapse
|
244
|
Kerensky RA, Bertolet BD, Epstein M. Late discovery of cor triatriatum as a result of unilateral pulmonary venous obstruction. Am Heart J 1995; 130:624-7. [PMID: 7661088 DOI: 10.1016/0002-8703(95)90379-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
|
245
|
Bulten HJ, Anthony PL, Arnold RG, Arrington J, Beise EJ, Belz E, Bosted PE, Chapman MS, Coulter KP, Dietrich FS, Ent R, Epstein M, Filippone BW, Gao H, Gearhart RA, Geesaman DF, Hansen J, Holt RJ, Jackson HE, Jones CE, Keppel CE, Kinney E, Kuhn SE, Lee K, Lorenzon W, Lung A, Makins NC, Margaziotis DJ, McKeown RD, Milner RG, Mueller B, Napolitano J, Nelson J, O'Neill TG, Papavassiliou V, Petratos GG, Potterveld DH, Rock SE, Spengos M, Szalata ZM, Tao LH, White JL, Zeidman B. Exclusive electron scattering from deuterium at high momentum transfer. PHYSICAL REVIEW LETTERS 1995; 74:4775-4778. [PMID: 10058596 DOI: 10.1103/physrevlett.74.4775] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
|
246
|
Epstein M. Thoughts without a thinker: Buddhism and psychoanalysis. Psychoanal Rev 1995; 82:391-406. [PMID: 7480395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
|
247
|
Dolfini S, Alarcon R, Arenhövel H, Beck R, Bernstein A, Bertozzi W, Boeglin W, Cardman L, Comfort J, Dale D, Dodson G, Dow K, Epstein M, Farkhondeh M, Gilad S, Görgen J, Holtrop M, Jordan D, Kim W, Kowalski S, Laszewski R, Mandeville J, Margaziotis D, Martinez D, McIlvain T, Miskimen R, Papanicolas C, Tieger D, Turchinetz W, Weinstein L, Williamson S. Out-of-plane quasielastic scattering from deuterium using polarized electrons. PHYSICAL REVIEW. C, NUCLEAR PHYSICS 1995; 51:3479-3482. [PMID: 9970453 DOI: 10.1103/physrevc.51.3479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
248
|
Abstract
Currently, a plethora of antihypertensive medications exists. One concern about the long-term use of many of these agents is that adverse effects may offset their benefits. Despite the availability of many newer agents, blood pressure continues to be inadequately controlled in the majority of treated hypertensive patients, and many still remain at higher risk of premature death than the general population. More than 60% of treated hypertensive patients fail to attain blood pressures of < 140/90 mmHg. The major factors that permit a rational choice of medication include demographic considerations such as race and age, coexisting disease, safety, patient acceptance (quality of life), potential drug interactions, and additional salutary effects. The role of nondiuretic monotherapy is an integral component of this discussion. Preliminary data indicate that the use of calcium-channel blockers, converting-enzyme inhibitors, and AII-receptor antagonists constitutes excellent therapy in many patients. The effects of medication on the metabolic and lipid profiles are also considered.
Collapse
|
249
|
Vesely DL, Norsk P, Gower WR, Chiou S, Epstein M. Release of kaliuretic peptide during immersion-induced central hypervolemia in healthy humans. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE. SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE (NEW YORK, N.Y.) 1995; 209:20-6. [PMID: 7724613 DOI: 10.3181/00379727-209-43872] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Kaliuretic peptide, a new peptide hormone consisting of amino acids 79-98 of the 126 amino acid atrial natriuretic factor (ANF) prohormone, is synthesized in the heart and is a potent stimulator of potassium excretion. The mechanism(s) controlling the release of kaliuretic peptide heretofore has not been defined. Because water immersion to the neck provides an acute central volume expansion identical to that produced by 2 liters of saline but without the plasma compositional change, immersion to the neck (NI) was utilized to assess kaliuretic peptide responses to acute central blood volume expansion in seven seated sodium-replete normal subjects. Since atrial natriuretic factor (ANF; amino acids 99-126 of the prohormone) originates from the amino acids adjacent to kaliuretic peptide in the ANF prohormone but is proteolytically cleaved from the rest of the prohormone before release, measurement of ANF was incorporated into this study to determine if there are differences with respect to release of these two portions of the ANF prohormone. Both kaliuretic peptide and ANF increased promptly with NI, with ANF peaking at 1 hr of immersion, whereas kaliuretic peptide peaked at the 3rd hr of immersion. With cessation of immersion, ANF decreased to preimmersion levels within 0.5 hr while kaliuretic peptide was still significantly (P < 0.05) elevated at 1 hr postimmersion. These findings indicate that kaliuretic peptide and ANF are released simultaneously but that kaliuretic peptide peak circulating concentration and its return to preimmersion values are prolonged compared with ANF. These last findings suggest a slower clearance from the circulation for kaliuretic peptide. The diuretic peak response to NI corresponded in a temporal manner to the peak circulating concentration of kaliuretic peptide, suggesting a possible physiologic role for kaliuretic peptide in modulating volume homeostasis in humans.
Collapse
|
250
|
Epstein M, Fauske HK. On the likelihood that underwater metal ignition is a vapor phase phenomenon. NUCLEAR ENGINEERING AND DESIGN 1995. [DOI: 10.1016/0029-5493(94)00887-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|